However, high serum cytokines such as IL-6 and IL-8 are often associated with malignancies that are resistant to treatment and have a poor prognosis [11–14], and it can be difficult to determine whether levels of these cytokines reflect response to Atezo+Bev treatment or indicate progression of the underlying tumor potential. This evidence concerns the gene CXCL8 and neoplasm.